RTW INVESTMENTS, LP - STOKE THERAPEUTICS INC ownership

STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 98 filers reported holding STOKE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.14 and the average weighting 0.6%.

Quarter-by-quarter ownership
RTW INVESTMENTS, LP ownership history of STOKE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$17,298,799
-62.9%
4,390,5580.0%0.36%
-58.9%
Q2 2023$46,671,632
+27.6%
4,390,5580.0%0.89%
+16.7%
Q1 2023$36,573,348
+2.4%
4,390,558
+13.4%
0.76%
+4.5%
Q4 2022$35,729,155
-23.8%
3,870,981
+6.0%
0.73%
-32.6%
Q3 2022$46,889,000
-2.8%
3,651,8230.0%1.08%
-13.2%
Q2 2022$48,241,000
-37.1%
3,651,823
+0.2%
1.25%
-21.5%
Q1 2022$76,711,000
-12.3%
3,644,2480.0%1.59%
+24.4%
Q4 2021$87,426,000
-5.7%
3,644,2480.0%1.28%
-8.7%
Q3 2021$92,710,000
-24.4%
3,644,2480.0%1.40%
-24.5%
Q2 2021$122,665,000
-13.3%
3,644,2480.0%1.85%
-16.2%
Q1 2021$141,543,000
-35.5%
3,644,248
+2.8%
2.21%
-40.0%
Q4 2020$219,495,000
+84.9%
3,544,2480.0%3.68%
+28.9%
Q3 2020$118,697,000
+40.5%
3,544,2480.0%2.86%
+20.3%
Q2 2020$84,459,000
+4.1%
3,544,2480.0%2.38%
-32.0%
Q1 2020$81,163,000
-19.1%
3,544,2480.0%3.49%
-7.7%
Q4 2019$100,373,000
+44.6%
3,544,248
+5.6%
3.79%
-8.2%
Q3 2019$69,401,000
-25.0%
3,355,4660.0%4.13%
-16.5%
Q2 2019$92,570,0003,355,4664.94%
Other shareholders
STOKE THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
ATP Life Science Ventures, L.P. 16,786,713$562,187,00075.80%
RTW INVESTMENTS, LP 3,544,248$118,697,0002.86%
Cormorant Asset Management, LP 1,537,807$51,501,0001.98%
Redmile Group, LLC 2,549,506$85,383,0001.57%
Birchview Capital, LP 40,000$1,340,0000.45%
HighVista Strategies LLC 17,082$572,0000.42%
Perceptive Advisors 671,978$22,505,0000.33%
GILDER GAGNON HOWE & CO LLC 1,490,153$49,905,0000.31%
Artal Group S.A. 270,750$9,067,0000.22%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 323$11,0000.20%
View complete list of STOKE THERAPEUTICS INC shareholders